Description
Description:
Gefticip is a medication primarily used in the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. Each tablet of Gefticip contains 250 mg of the active ingredient gefitinib, which belongs to a class of medications known as tyrosine kinase inhibitors.
Indications:
Gefticip is indicated for the treatment of:
- Non-small cell lung cancer (NSCLC) that has spread to other parts of the body (metastatic NSCLC) in patients with certain genetic mutations, such as mutations in the epidermal growth factor receptor (EGFR) gene.
Mechanism of Action:
Gefitinib works by inhibiting the activity of the epidermal growth factor receptor (EGFR), a protein that plays a role in the growth and spread of cancer cells. By blocking EGFR signaling, gefitinib helps to slow down or stop the growth of cancer cells, thereby reducing tumor size and progression.
Administration:
Gefticip tablets are taken orally with or without food, as directed by a healthcare professional. The dosage and duration of treatment may vary depending on the patient’s medical condition, response to therapy, and other factors.
Dosage:
The recommended dosage of Gefticip for the treatment of metastatic NSCLC is usually 250 mg taken once daily. It is essential to follow the prescribed dosage regimen provided by a healthcare professional.
Side Effects:
Common side effects of Gefticip may include:
- Diarrhea
- Rash
- Acne
- Dry skin
- Nausea
- Vomiting
- Loss of appetite
- Fatigue
- Mouth sores
- Changes in liver function tests
Contraindications:
Gefticip is contraindicated in patients with a known hypersensitivity to gefitinib or any other ingredients in the formulation. It should not be used in patients with severe liver impairment or severe kidney impairment.
Storage:
Gefticip should be stored at room temperature (20°C to 25°C) in its original packaging, protected from light and moisture. Keep out of reach of children and pets.
Prescription Required:
Gefticip is a prescription medication, and its use should be supervised by a qualified healthcare professional.
Note:
This medication description provides only general information about Gefticip and should not be used as a substitute for professional medical advice. Always consult a healthcare professional for guidance on the appropriate use, dosage, and potential risks and benefits of Gefticip in your specific situation.
Reviews
There are no reviews yet.